Adverse events · participants with long‐term antidepressants for depressive disorders
1 finding from 1 review
Depressive symptoms · participants with long‐term antidepressants for depressive disorders
1 finding from 1 review
Anxiety · participants with long‐term antidepressants for depressive disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · participants with long‐term antidepressants for depressive disorders
1 finding from 1 review
Social and occupational functioning · participants with long‐term antidepressants for depressive disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Relapse · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Withdrawal symptoms · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depressive symptoms · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Anxiety · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Quality of life · participants with long‐term antidepressants for depressive or anxiety disorders
1 finding from 1 review
Social and occupational functioning · participants with long‐term antidepressants for depressive or anxiety disorders
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
MST vs ECT ‐ adverse events that led to discontinuation of treatment (short term) · patients with schizophrenia
1 finding from 1 review
Withdrawals due to adverse events · adults with a history of SAD who do not fulfil criteria for major depressive disorder
Bupropion XL showed no clear difference in discontinuation due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether bright white light therapy changes overall discontinuation ( compared with infrared light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether bright white light therapy changes overall discontinuation ( compared with no light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether infrared light therapy changes overall discontinuation ( compared with no light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · All participants were known SAD patients who had been successfully treated with conventional light therapy in previous winters
It is very uncertain whether light therapy changes overall discontinuation ( compared with no light therapy (very low certainty).
1 finding from 1 review
Overall discontinuation ( · adults with a history of SAD but without depressive symptoms when treatment started
It is very uncertain whether mindfulness‐based cognitive therapy (MBCT) changes overall discontinuation rate compared with treatment (very low certainty).
1 finding from 1 review